How Do Aromatase Inhibitors Influence Cardiovascular Risk in Hormonal Therapy?
Aromatase inhibitors modulate cardiovascular risk by altering estrogen's protective effects, an outcome defined by individual hormonal context.
HRTioAugust 1, 2025